Electrum Discovery Corp.

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Apr 14, 2015) - Medgold Resources Corp. (TSX VENTURE:MED) (the "Company") announces that the TSX Venture Exchange has conditionally approved the proposed issuance of up to 435,520 common shares of the Company to Dan James in part consideration for his ongoing services as the Company's President (see Medgold news release February 19, 2015). The shares will be issued in quarterly [...]

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 26, 2015) - Medgold Resources Corp. (TSX VENTURE:MED) (the "Company") is pleased to provide an exploration update on the Lagares gold project. The project is joint ventured to Centerra Gold Inc. ("Centerra"), who are earning in to 51% of the project by spending $3 million over 3 years, and have the right to earn an additional 19% by spending a further $3 million over 2 [...]

Medgold Resources announces that its management has determined that it is in the best interests of the Company to extend the expiry date of certain previously issued private placement warrants. Accordingly, subject to TSX Venture Exchange acceptance, the expiry date of outstanding warrants to purchase up to 2,166,667 common shares at $0.1665 per share will be extended by one year to April 11, 2016. The securities referred [...]

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 16, 2015) - Medgold Resources Corp. (TSX VENTURE:MED), the European focused gold exploration company, is pleased to announce that it has reached an agreement with Koza Ltd. ("Koza"), a subsidiary of the Turkish gold mining company, Koza Altın İsletmeleri A.Ş., whereby Koza has been granted an option to acquire up to a 75% interest in Medgold's Boticas gold project in northern Portugal. Koza can earn an initial 55% interest in the project by spending CAD $3 million on exploration activities on the property over three years, of which $500,000 is committed to be spent in the first year. Upon completion of the initial $3m expenditures, Koza can earn an additional 20% interest by spending a further $3m on ex... [...]

Medgold Resources is pleased to advise that it has closed its previously announced non-brokered private placement by issuing 2,272,728 units at $0.11 per unit, for gross proceeds of $250,000. Each unit consists of one common share and one warrant, each warrant entitling the holder to purchase one additional common share of the Company at $0.16 for one year from closing. The Company also paid $660 cash and issued 42,000 [...]

Medgold Resources is pleased to announce that it proposes to arrange, subject to TSX Venture Exchange approval, a non-brokered private placement financing of up to 2.0 million units at $0.11 per unit, for proceeds of up to $220,000. Each unit will consist of one common share and one warrant entitling the holder to purchase one additional common share of the Company at $0.16 for one year from closing. The Company may pay [...]

Medgold Resources announces that its Board of Directors has determined that it is in the best interests of the Company to extend the expiry date of a debenture in the principal amount of $975,000 that was previously issued by the Company pursuant to a private placement. Accordingly, subject to TSX Venture Exchange acceptance, the expiry date of the debenture, which is convertible into 2,166,667 common shares at a [...]

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec 9, 2014) - Medgold Resources Corp. (TSX VENTURE:MED), the European-focused gold exploration company, is pleased to announce that it has granted to Centerra Gold Inc. (TSX:CG) the option to acquire up to 70% of the Lagares, Balazar, Castelo de Paiva and Valongo licences in northern Portugal (collectively the "Valongo Belt Property"). Dan James, the President of Medgold, said [...]

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec 2, 2014) - Medgold Resources Corp. (TSX VENTURE:MED), the European-focused gold exploration company, is pleased to announce high-grade gold results over broad contiguous intersections from a recent channel sampling program at the Lagares Gold Project in northern Portugal. Channel-Chip Sampling Highlights Management is extremely encouraged by the first round of channel [...]

Medgold announces that its Board of Directors has determined that it is in the best interests of the Company to amend the exercise price of certain common share purchase warrants issued in early 2014 pursuant to a private placement. In order to encourage exercise of the Warrants, the Warrant holders have been given the right, for a limited time, to elect to exercise up to 60% of their Warrants at an exercise price of [...]